Granulomatous disease and the two faces of Janus: divergent effects of tofacitinib therapy for inflammatory arthritis. uri icon

Overview

publication date

  • September 7, 2021

Research

keywords

  • Antirheumatic Agents
  • Arthritis

Identity

Scopus Document Identifier

  • 85123879475

Digital Object Identifier (DOI)

  • 10.55563/clinexprheumatol/2hu4yl

PubMed ID

  • 34494956

Additional Document Info

volume

  • 40

issue

  • 1